"La Clinique médicale et cardiologique d’Aressy dispose de 123 lits et 35 places installés. Elle accueille 6000 patients par an dans le cadre d’un projet médical multidisciplinaire, avec 2 activités principales en hospitalisation complète et de jour : - Médecine : Cardiologique, Médecine Polyvalente et Gériatrique - Soins de Suite et de Réadaptation : polyvalents, cardiologiques et pneumologiques"

During the past decade, Clinique Cardiologique Aressy conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinique Cardiologique Aressy" are "Bradycardia" (1 trials), "Heart Block" (1 trials), "Sick Sinus Syndrome" (1 trials), "Ventricular Fibrillation" (1 trials) and "Ventricular Tachycardia" (1 trials). Many other conditions were trialed in "Clinique Cardiologique Aressy" in a lesser frequency.

Most popular intervention types in "Clinique Cardiologique Aressy" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Endotak Reliance" (1 trials) and "Insignia Ultra and Insignia AVT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Cardiologique Aressy" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinique Cardiologique Aressy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinique Cardiologique Aressy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Cardiologique Aressy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".